## Cytokine-Mediated Cartilage Degradation in Osteoarthritis **Key Point:** IL-1 and TNF-α are the primary pro-inflammatory cytokines driving cartilage matrix degradation in osteoarthritis through upregulation of matrix metalloproteinases (MMPs) and suppression of anabolic factors. ### Mechanism of Cartilage Destruction 1. **IL-1 and TNF-α Actions** - Stimulate chondrocytes to produce matrix metalloproteinases (MMP-1, MMP-3, MMP-13) - Increase production of nitric oxide (NO) and prostaglandin E~2~ (PGE~2~) - Suppress synthesis of proteoglycans and type II collagen - Promote apoptosis of chondrocytes - Activate synovial fibroblasts and macrophages 2. **Downstream Effects** - MMPs degrade collagen and proteoglycans - Loss of cartilage matrix integrity - Reduced chondrocyte viability - Perpetuation of inflammatory cycle ### Comparative Roles of Other Cytokines | Cytokine | Role in OA | Effect on Cartilage | |----------|-----------|---------------------| | IL-1 & TNF-α | Catabolic (primary) | Degradation | | IL-10 | Anti-inflammatory | Protective | | TGF-β | Anabolic | Cartilage repair | | IL-4 | Anti-inflammatory | Protective | | IL-6 | Pro-inflammatory | Contributes to inflammation | **High-Yield:** IL-1 is considered the "master cytokine" in OA pathogenesis. Blocking IL-1 and TNF-α is a therapeutic target in OA management. **Mnemonic:** **CAM** = **C**artilage degradation by **A**ctivated **M**acrophages (via IL-1/TNF-α) **Clinical Pearl:** Elevated synovial fluid levels of IL-1 and TNF-α correlate with disease progression and cartilage loss in osteoarthritis patients. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.